Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma

Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma

A 65-year-old man with nonsevere aplastic anemia received rabbit anti-thymocyte globulin and cyclosporine and partially responded. Six months after the initiation of treatment, he was diagnosed with stage IV angioimmunoblastic T-cell lymphoma and received chemotherapy. PET/CT scan analysis indicated...

Full description

Bibliographic Details
Main Authors: Fumi Nakamura, Yuka Nakamura, Yasuhito Nannya, Honoka Arai, Kei Shimbo, Yuko Nakamura, Sachiko Seo, Ko Sasaki, Motoshi Ichikawa, Seishi Ogawa, Kinuko Mitani
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Leukemia Research Reports
Subjects:
Eltrombopag
Aplastic anemia
Myelodysplastic syndromes
Angioimmunoblastic t-cell lymphoma
3q26 abnormalities
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048922000176

Internet

http://www.sciencedirect.com/science/article/pii/S2213048922000176

Similar Items